Hepatitis C treatment with all-oral direct-acting antivirals: Effectiveness and tolerance in a multicenter, prospective, observational study from French general hospitals (APROVVIE, ANGH).
CONCLUSIONS: Second generation DAAs combinations are as effective and well tolerated in a « real-world » population as in clinical trials. Further studies are needed on renal tolerance.
PMID: 30853287 [PubMed - as supplied by publisher]
Source: Presse Medicale - Category: General Medicine Authors: Pariente A, Arpurt JP, Rémy AJ, Rosa-Hézode I, Causse X, Heluwaert F, Macaigne G, Henrion J, Renou C, Schnee M, Salloum H, Hommel S, Pilette C, Arotcarena R, Barjonet G, Lison H, Bourhis F, Jouannaud V, Pauwels A, Le eaBricquir Y, Geagea E, Condat B, Ri Tags: Presse Med Source Type: research
More News: Academia | Cancer & Oncology | Carcinoma | Cirrhosis | Clinical Trials | France Health | Gastroenterology | General Medicine | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Liver Cancer | Norvir | Oral Cancer | Study | Urology & Nephrology | Virology